Utjecaj desflurana i sevoflurana na razine oksidativnog stresa u tkivima štakora by Hülya Türkan et al.
113Türkan H, et al. EFFECTS OF SEVOFLURANE AND DESFLURANE ON OXIDATIVE STRESSArh Hig Rada Toksikol 2011;62:113-119
DOI: 10.2478/10004-1254-62-2011-2096
Scientifi c Paper
OXIDATIVE AND ANTIOXIDATIVE EFFECTS
OF DESFLURANE AND SEVOFLURANE ON
RAT TISSUE IN VIVO
Hülya TÜRKAN1, Ahmet AYDIN2, Ahmet SAYAL2, Ayşe EKEN2, Cemal AKAY2, 
and Bensu KARAHALİL3
Anaesthesiology and Reanimation Clinic, Kasimpasa Military Hospital, Istanbul1, Gülhane Military 
Medical Academy2, Gazi University Faculty of Pharmacy, Ankara3, Turkey
Received in February 2011
CrossChecked in May 2011
Accepted in May 2011
General anaesthetics are often used in patients who are under oxidative stress due to a critical illness or 
surgical trauma. Some anaesthetics may worsen oxidative stress and some may act as antioxidants. The 
aim of this study was to evaluate liver, brain, kidney, and lung tissue oxidative stress in rats exposed to 
desfl urane and sevofl urane and in unexposed rats. The animals were divided in three groups: control 
(received only air); sevofl urane (8 %), and desfl urane (4 %). After four hours of exposure, we evaluated 
the levels of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), 
Cu, and Zn. Exposure to either of the anaesthetics signifi cantly increased lung MDA levels compared to 
control (Mann-Whitney U test; P<0.05), probably because it is the tissue directly exposed to anaesthetic 
gases. Oxidative stress and antioxidant activity in other tissues varied between the desfl urane and sevofl urane 
groups. Our results suggest that anaesthesiologist should not only be aware of the oxidative or antioxidative 
potential of anaesthetics they use, but should also base their choices on organs which are the most affected 
by their oxidative action.
KEY WORDS: Cu, glutathione peroxidase, malondialdehyde, reactive oxygen species, superoxide 
dismutase, volatile anaesthetics, Zn
Free radicals are products of normal aerobic 
metabolism (1). If free radical production exceeds 
antioxidant cell activity, this is defi ned as oxidative 
stress, which impairs cell membrane, damages DNA, 
and contributes to all infl ammatory diseases (2).
Volatile anaesthetics cause an ischemia-
reperfusion (I/R) injury, which is a complex 
phenomenon resulting in greater production of reactive 
oxygen species (ROS). Eroglu et al. (3) have clearly 
demonstrated increase in infl ammatory mediators, I/R 
injury, and ROS in generalised infl ammatory reactions 
involving the production of leukocytes. Airway 
infl ammation appears to play a central role in the 
development of lung diseases such as asthma and 
chronic obstructive pulmonary disease, and Rükgauer 
et al. (4) demonstrated increased oxidative stress in 
the blood of these patients (4).
Malondialdehyde (MDA) is an end-product of the 
degradation of polyunsaturated lipids by ROS (2) and 
is used as a biomarker of oxidative stress. On the other 
hand, the most common markers of cell antioxidant 
activity are the enzymes superoxide dismutase (SOD) 
and glutathione peroxidase (GSH-Px). In addition 
trace elements such as Cu and Zn contribute to 
antioxidant enzymatic activity (5).
Patients with an imbalance between ROS production 
and antioxidant activity due to surgical trauma are a 
specifi c population at risk. Therefore, when these 
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patients are to be anaesthetised, it is important to select 
an anaesthetic which will burden their antioxidant 
defences the least.
S e v o f l u r a n e  ( 2 , 2 , 2 - t r i f l u o r o - 1 -
[trifluoromethyl]ethyl fluoromethyl ether) and 
desf lurane  (2 ,2 ,2- t r i f luoro-1- f luoroethyl -
difluoromethyl ether) are very common volatile 
anaesthetics used for general anaesthesia. Desfl urane 
acts the most rapidly among volatile anaesthetics due 
to its low solubility in blood (6), which is related to 
its lowest blood-gas partition coefficient (7). In 
addition, it metabolises far less to F- compounds than 
sevofl urane (8). Ideally, a volatile anaesthetic should 
provide smooth and reliable induction and maintenance 
of general anaesthesia with minimal effects on other 
organ systems.
The purpose of our study was to investigate the 
levels of oxidative stress induced by sevofl urane and 
desfl urane in rats using MDA as a marker of oxidative 
stress and enzymes SOD and GSH-Px (and their co-
factors Cu and Zn) as markers of antioxidative activity. 
We also tried to evaluate tissue-specifi c variations 
between rat liver, kidney, brain, and lung.
MATERIALS AND METHODS
The study protocol was approved by the Animal 
Care and Utilization Committee of the Gulhane 
Military Medical Academy (GMMA) School of 
Medicine, Ankara, Turkey.
Animals
The study included 21 male Wistar rats (300 g to 
365 g body weight) obtained from the GMMA Animal 
Research Facility. The rats were housed in cages under 
standard hygienic conditions, with light and dark 
cycles exchanging every 12 h. They received standard 
rat feed and had free access to water.
Experimental design
The rats were randomised into three groups of 
seven: unexposed control, sevofl urane, and desfl urane 
group. The animals were placed in a vented seven-litre 
inhalation chamber. Vented chambers provide optimal 
temperature, humidity, and inhaled gas composition. 
The chamber was preheated to maintain animal body 
temperature. After closing the lid, the rats were 
exposed to 3.5 % to 4 % sevofl urane or 7 % to 8 % 
desfl urane vaporised at a continuous oxygen fl ow of 
3 L min-1 until they lost the righting refl ex. Constant 
vacuum above the chamber was used to capture excess 
gas and when the animals lost the righting refl ex, 
sevofl urane or desfl urane concentrations were lowered 
to allow the animals to breathe spontaneously. 
Anaesthesia continued for four hours during which 
we monitored animal movement and breathing. At the 
end of the anaesthesia, the rats were decapitated, and 
their brains, lungs, livers, and kidneys collected and 
fi xed with formol. Tissue samples were minced and 
homogenised in a cold potassium chloride (KCl) 
solution (1.15 %) and centrifuged at 4,400 rpm and 
+4 °C for 15 minutes. The supernatants were then used 
to analyse MDA, SOD, GSH-Px, Cu, and Zn, as 
described below.
Biochemical analysis of oxidant/antioxidant 
parameters
All chemicals and reagents were purchased from 
Sigma-Aldrich (St. Luis, USA) and Merck (Darmstadt, 
Germany). Cu,Zn-SOD, GSH-Px, and MDA were 
m e a s u r e d  u s i n g  a  S h i m a d z u  U V- 2 1 0 0 S 
spectrophotometer (Kyoto, Japan).
Cu, Zn-SOD activities in supernatant were 
measured using a method described earlier (9, 10). 
Briefl y, 50 μL of supernatant was mixed with 850 μL 
of substrate solution containing 0.05 mmol L-1 
xanthine sodium and 0.025 mmol L-1 2-(4-iodophenyl)-
3-(4-nitrophenol)-5-phenyltetrazolium chloride (INT) 
in a buffer solution containing 50 mmol L-1 CAPS 
(3-(cyclohexylaminol)-1-propanesulfonic acid) and 
0.094 mmol L-1 EDTA (pH 10.2). One hundred 
microlitres of xanthine oxidase (80 U L-1) was added 
to the mixture and increase in absorbance was 
observed at 505 nm for 3 min.
GSH-Px activities in supernatant were measured 
using a method described earlier (10). Briefl y, we 
prepared a reaction mixture containing 1 mmol L-1 
Na2EDTA, 2 mmol L
-1 reduced glutathione, 
0.2 mmol L-1 NADPH, 4 mmol L-1 sodium azide, and 
1000 U glutathione reductase in 50 mmol L-1 TRIS 
buffer (pH 7.6). Fifty microlitres of the supernatant 
and 950 μL of the reaction mixture were mixed and 
incubated at 37 °C for 5 min. The reaction was 
initiated by adding 8.8 mmol L-1 hydrogen peroxide 
and a decrease in absorbance was recorded at 340 nm 
for 3 min.
Lipid peroxidation was determined by measuring 
MDA, using the method described by Jain (10). 
Tetramethoxy propane solution was used as standard. 
This assay is based on the formation of red adduct in 
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acidic medium between thiobarbituric acid and MDA; 
the product of lipid peroxidation was measured at 
532 nm.
For Cu and Zn measurements, tissue samples were 
digested with a mixture of nitric acid and hydrogen 
peroxide in a Milestone microwave digestor Mega 
1200 (Bergamo, Italy) and Cu and Zn determined with 
a flame atomic absorption spectrometer (Varian 
SpectraAA 30/40, Mulgrave, Australia) according to the 
instrument procedure (11). The flame was an air-
acetylene mixture. The calibration curve interval for Cu 
was (2 to 6) μg mL-1 and for Zn (0.5 to 1.5) μg mL-1.
Statistical analysis
For statistical analysis we used SPSS statistics 
software (version 13.0). Data were expressed as 
medians and ranges. The differences between the 
groups were compared using the Mann-Whitney U 
test. A P value of less than 0.05 was considered 
statistically signifi cant.
RESULTS
All animals completed the experiment, that is, all 
survived until sacrifi ce.
MDA concentrations
Compared to controls, MDA signifi cantly dropped 
in the sevofl urane group liver, kidney, and brain and 
in the desflurane group liver. However, they 
signifi cantly increased in the lungs of both anaesthetic-
exposed groups. MDA in the desfl urane group was 
slightly higher than in the sevofl urane group in the 
liver and lung, but the differences were not signifi cant 
(Table 1).
SOD and GSH-Px concentrations
The only signifi cant differences from control were 
higher brain and lower liver SOD in the desfl urane 
group. The sevofl urane group showed no signifi cant 
differences in SOD concentrations from control (Table 
2).
Table 1 MDA levels in the liver, kidney, brain, and lung tissues of rats exposed to sevofl urane and desfl urane
Tissue MDA / nmol g
-1
Sevofl urane Group Desfl urane Group Control Group
Liver Median 1.36* 1.19* 1.72Range 1.29 to 1.53 1.06 to 1.62 1.20 to 2.97
Kidney Median 1.54* 2.11 2.11Range 1.33 to 1.64 1.42 to 2.53 1.46 to 2.35
Brain Median 0.89* 0.95 1.01Range 0.82 to 0.95 0.88 to 1.01 0.91 to 1.07
Lung Median 1.08* 1.06* 0.92Range 0.91 to 1.32 0.97 to 1.12 0.85 to 1.03
Each group consisted of 7 rats
* different from control P<0.05, Mann – Whitney U test
Table 2 SOD levels in the liver, kidney, brain, and lung tissues of rats exposed to sevofl urane and desfl urane
Tissue SOD / U g
-1
Sevofl urane Group Desfl urane Group Control Group
Liver Median 1729 1575* 1897Range 1192 to 1987 1435 to 1811 1308 to 2082
Kidney Median 1248 1192 1137Range 492 to 1370 257 to 1503 566 to 1192
Brain Median 194 269* 185Range 116 to 223 111 to 373 566 to 1192
Lung Median 161 185 161Range 128 to 234 111 to 245 122 to 213
Each group consisted of 7 rats
* different from control P<0.05, Mann – Whitney U test
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As for GSH-Px, only the sevofl urane group kidney 
tissue showed signifi cantly lower levels, but even these 
were within the control range. There were no other 
signifi cant changes in either group (Table 3).
Zn and Cu levels
Zinc was significantly higher in the lung and 
kidney tissues of the desfl urane group and only in the 
lung tissue of the sevofl urane group (Table 4). The 
only signifi cant change in Cu levels was a drop in the 
lung tissue of the desfl urane group (Table 5).
DISCUSSION
Oxidative stress occurs in many human diseases 
and signifi cantly contributes to their development (12). 
The protective action of drugs against oxidative stress 
Table 3 GSH-Px levels in the liver, kidney, brain, and lung tissues of rats exposed to sevofl urane and desfl urane
Tissue GSH-Px / U g
-1
Sevofl urane Group Desfl urane Group Control Group
Liver Median 82.07 70.00 67.68Range 60.75 to 92.73 55.54 to 77.77 17.77 to 90.74
Kidney Median 43.39* 54.14 47.94Range 37.19 to 48.35 46.12 to 65.21 37.44 to 67.61
Brain Median 61.74 70.83 64.88Range 56.61 to 73.72 62.73 to 78.02 53.14 to 72.89
Lung Median 81.15 75.45 83.80Range 71.49 to 100.00 53.14 to 100.00 68.68 to 98.35
Each group consisted of 7 rats
* different than control P<0.05, Mann – Whitney U test
Table 4 Zn levels in the liver, kidney, brain, and lung tissues of rats exposed to sevofl urane and desfl urane
Tissue Zn / μg
 g-1
Sevofl urane Group Desfl urane Group Control Group
Liver Median 27.06 25.62 26.61Range 22.50 to 30.15 19.95 to 29.52 18.60 to 30.78
Kidney Median 22.26 22.89* 20.46Range 14.43 to 24.69 20.49 to 24.33 15.48 to 22.41
Brain Median 6.36 7.08 6.39Range 5.43 to 15.72 4.80 to 11.40 4.95 to 11.22
Lung Median 11.37* 10.64* 9.51Range 9.36 to 14.97 9.82 to 11.91 6.91 to 11.43
Each group consisted of 7 rats
* different than control P<0.05, Mann – Whitney U test
Table 5 Cu levels in the liver, kidney, brain, and lung tissues of rats exposed to sevofl urane and desfl urane
Tissue Cu/ μg
 g-1
Sevofl urane Group Desfl urane Group Control Group
Liver Median 2.70 3.07 2.57Range 1.92 to 2.93 1.73 to 3.58 2.11 to 2.93
Kidney Median 2.17 2.61 2.65Range 1.83 to 2.84 2.18 to 2.77 0.75 to 3.37
Brain Median 0.68 0.56 0.59Range 0.49 to 3.90 0.45 to 0.76 0.52 to 1.04
Lung Median 1.12 0.98* 1.18Range 0.92 to 1.39 0.45 to 1.26 1.10 to 1.52
Each group consisted of 7 rats
* different than control P<0.05, Mann – Whitney U test
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is particularly important when organism’s antioxidant 
defences are down (13). Anaesthetic drugs that cause 
less oxidative stress and have more antioxidant 
properties are therefore a better choice, especially in 
post-operative or critical patients who are already 
under increased oxidative stress (14, 15). Many studies 
have investigated antioxidative properties of 
intravenous anaesthetics, propofol in particular (16-
18). Oztürk et al. (19) and Nakahata et al. (20) found 
that propofol lowered oxidative stress, especially in 
rat brain. In a study on rats similar to ours, Abdelmajeed 
(21) found that intravenous diazepam increased 
oxidative damage to the rat liver, kidney, and heart, 
which was accompanied by increased nitric oxide 
(NO) levels.
Findings from animal studies on volatile 
anaesthetics and tissue oxidative stress are limited 
(22). Awad et al. (23) showed that halothane caused 
free radical formation and impaired rat liver antioxidant 
defences in vivo. Sato et al. (25) found that sevofl urane 
also had the potential to cause lipid peroxidation in 
vivo and in vitro. Similarly, SOD and GSH-Px levels 
in our study showed weaker antioxidative potential of 
sevofl urane and desfl urane in rat liver and kidney, 
respectively.
Kudo et al. (24) studied antioxidant activity in rats 
with ischaemic brain injury treated with isofl urane, 
sevofl urane, and halothane. These volatile anaesthetics 
provided no direct protection against oxidative stress. 
This is similar to our fi nding that sevofl urane did not 
increase SOD and GSH-Px levels, and therefore 
provided no antioxidative protection of rat brain.
In swine lungs, desfl urane seemed to induce local 
and systemic oxidative stress, whereas sevofl urane 
showed antioxidative properties (26). This is not 
consistent with our results, perhaps due to a different 
experimental design, as we did our research on rats 
and we did not mechanically ventilate them as 
Allaochiche et al. (26) did with swine. Our experimental 
design, which included controlled breathing 
environment and a relatively long time of exposure (4 
hours), aimed to underline the relation between 
volatile anaesthetics and oxidative stress. What we 
have found out is that the lungs take the most of 
oxidative damage, being the first tissue exposed 
anaesthetic gas.
Our findings show that both sevoflurane and 
desfl urane caused an increase in MDA levels only in 
the lung, while in other tissues they barely altered the 
activity of antioxidative enzymes. This suggests that 
anaesthesiologist should not only be aware of the 
oxidative or antioxidative potential of anaesthetics 
they use, but should also base their choices on organs 
which are the most affected by their oxidative 
action.
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Sažetak
UTJECAJ DESFLURANA I SEVOFLURANA NA RAZINE OKSIDATIVNOG STRESA U TKIVIMA 
ŠTAKORA
Poznato je da kirurške zahvate prati porast razine oksidativnog stresa, kako zbog stvaranja slobodnih 
kisikovih radikala tako i zbog smanjene aktivnosti obrambenih sustava koji se mogu oduprijeti njihovu 
djelovanju. Stoga su saznanja o antioksidativnom kapacitetu anestetika koji se primjenjuju prije nekoga 
kirurškog zahvata vrlo važna i od velikog su kliničkog značenja. Sevofl uran i desfl uran su inhalacijski 
anestetici koji se učestalo rabe u svrhu uvođenja bolesnika u anesteziju. Cilj ovog istraživanja bio je utvrditi 
razine oksidativnog stresa u različitim tkivima štakora i usporediti razlike u odgovoru tkiva na izlaganje 
navedenim anesteticima. U tu svrhu razine oksidativnog stresa izmjerili smo u jetri, mozgu, bubrezima i 
plućima štakora podijeljenih u tri eksperimentalne skupine. Kontrolna skupina udisala je samo zrak, dok 
su druge dvije skupine izložene 8 %-tnomu sevofl uranu te 4 %-tnomu desfl uranu tijekom 4 h. Nakon 
završetka obrade životinje su žrtvovane i uzimani su im uzorci tkiva za biokemijske analize. Mjerena je 
razina malondialdehida (MDA), aktivnost enzima superoksid dismutaze (SOD) i glutation peroksidaze 
(GSH-Px) te razine bakra i cinka. Izloženost anesteticima izazvala je oksidativni stres u plućima, na što 
upućuje značajno povišena razina MDA (Mann-Whitney U-test P<0.05) izmjerena u plućnom tkivu štakora 
obiju izloženih skupina u odnosu na kontrolu. Plućno je tkivo u odnosu na ostala tkiva podložnije štetnim 
utjecajima reaktivnih kisikovih radikala vjerojatno stoga što je ono prvo izloženo plinovitim anesteticima 
nakon njihova ulaska u organizam. Razine oksidativnog stresa i antioksidativne aktivnosti koje smo izmjerili 
u ostalim tkivima bile su različite te su ovisile o primijenjenom anestetiku. Na osnovi dobivenih rezultata 
možemo zaključiti da bi se zbog različitog odgovora tkiva izbor anestetika trebao provoditi na individualnoj 
osnovi.
KLJUČNE RIJEČI: Cu, glutation peroksidaza, malondialdehid, reaktivni kisikovi radikali, superoksid 
dismutaza, inhalacijski anestetici, Zn
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